# Hardwins - Squamous Cell Carcinoma Head & Neck (Surgery/RT)

> **NCT00188318** · PHASE2 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 169 (actual)

## Conditions studied

- Carcinoma, Squamous Cell

## Interventions

- **PROCEDURE:** hyperfractionated accelerated radiotherapy

## Key facts

- **NCT ID:** NCT00188318
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-06
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 169 (ACTUAL)
- **Last updated:** 2016-02-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00188318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00188318, "Hardwins - Squamous Cell Carcinoma Head & Neck (Surgery/RT)". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT00188318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*